Lung disease associated with the IVS8 5T allele of the CFTR gene

被引:80
作者
Noone, PG
Pue, CA
Zhou, ZQ
Friedman, KJ
Wakeling, EL
Ganeshananthan, M
Simon, RH
Silverman, LM
Knowles, MR
机构
[1] Univ N Carolina, Div Pulm, Cyst Fibrosis Pulm Res & Treatment Ctr, Dept Med, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Pathol & Lab Med, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA
[3] Univ London, Inst Child Hlth, London WC1N 1EH, England
[4] Pinnacle Hlth Polyclin Hosp, Harrisburg, PA USA
[5] Univ Michigan, Ann Arbor, MI 48109 USA
关键词
D O I
10.1164/ajrccm.162.5.2003160
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Cystic fibrosis is caused by mutations in the cystic fibrosis transmembrane regulator (CFTR) gene. The 5T allele in intron 8 (IVS8) causes abnormal splicing in the CFTR gene, and is associated with lung disease when it occurs in cis with a missense mutation in the CFTR gene, R117H. However, the 5T variant alone has not been reported to cause lung disease. We describe two adult female patients with CF-like lung disease associated with the 5T allele. One patient's genotype is 5T-TG12-M470V/5T-TG12-M470V, and the other is Delta F508/5T-TG12-M470V; full sequencing of the CFTR gene revealed no other mutation on the same allele as the 5T variant. The levels of full-length CFTR mRNA in respiratory epithelia were very low in these patients (11 and 6%, respectively, of total CFTR mRNA expression). Both patients had defective CFTR-mediated chloride conductance in the sweat ductal and/or acinar epithelia (sweat chloride, mmol/L, mean +/- SEM: 40.0 +/- 5.0 [n = 8 samples] and 80.0 +/- 3.5 [n = 6 samples]) and airway epithelia (mV, mean +/-: SEM CFTR-mediated Cl- conductance of 1.2 +/- 2.2 [n = 5 studies] and -6.75 +/- 8.1 [n = 4 studies]). These data suggest that the 5T polythymidine tract sequence on specific haplotype backgrounds (TG12 and M470V) may cause a low level of full-length functional CFTR protein and CF-like lung disease.
引用
收藏
页码:1919 / 1924
页数:6
相关论文
共 34 条
[1]   CONGENITAL BILATERAL ABSENCE OF THE VAS-DEFERENS - A PRIMARILY GENITAL FORM OF CYSTIC-FIBROSIS [J].
ANGUIANO, A ;
OATES, RD ;
AMOS, JA ;
DEAN, M ;
GERRARD, B ;
STEWART, C ;
MAHER, TA ;
WHITE, MB ;
MILUNSKY, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (13) :1794-1797
[2]  
BEAUDET AL, 1991, AM J HUM GENET, V48, P1213
[3]   HYPOSECRETION OF BETA-ADRENERGICALLY INDUCED SWEATING IN CYSTIC-FIBROSIS HETEROZYGOTES [J].
BEHM, JK ;
HAGIWARA, G ;
LEWISTON, NJ ;
QUINTON, PM ;
WINE, JJ .
PEDIATRIC RESEARCH, 1987, 22 (03) :271-276
[4]   MUTATIONS IN THE CYSTIC-FIBROSIS GENE IN PATIENTS WITH CONGENITAL ABSENCE OF THE VAS-DEFERENS [J].
CHILLON, M ;
CASALS, T ;
MERCIER, B ;
BASSAS, L ;
LISSENS, W ;
SILBER, S ;
ROMEY, MC ;
RUIZROMERO, J ;
VERLINGUE, C ;
CLAUSTRES, M ;
NUNES, V ;
FEREC, C ;
ESTIVILL, X .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (22) :1475-1480
[5]   GENETIC-BASIS OF VARIABLE EXON-9 SKIPPING IN CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MESSENGER-RNA [J].
CHU, CS ;
TRAPNELL, BC ;
CURRISTIN, S ;
CUTTING, GR ;
CRYSTAL, RG .
NATURE GENETICS, 1993, 3 (02) :151-156
[6]   Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis [J].
Cohn, JA ;
Friedman, KJ ;
Noone, PG ;
Knowles, MR ;
Silverman, LM ;
Jowell, PS .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (10) :653-658
[7]   Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes - The polymorphic (TG)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation [J].
Cuppens, H ;
Lin, W ;
Jaspers, M ;
Costes, B ;
Teng, H ;
Vankeerberghen, A ;
Jorissen, M ;
Droogmans, G ;
Reynaert, I ;
Goossens, M ;
Nilius, B ;
Cassiman, JJ .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (02) :487-496
[8]   Linkage disequilibrium between the M470V variant and the IVS8 polyT alleles of the CFTR gene in CBAVD [J].
de Meeus, A ;
Guittard, C ;
Desgeorges, M ;
Carles, S ;
Demaille, J ;
Claustres, M .
JOURNAL OF MEDICAL GENETICS, 1998, 35 (07) :594-596
[9]  
Friedman KJ, 1997, HUM MUTAT, V10, P108, DOI 10.1002/(SICI)1098-1004(1997)10:2<108::AID-HUMU3>3.0.CO
[10]  
2-G